Ubrelvy and Reyvow Will Be New Options to Treat Migraine

Ubrelvy (yoo-BREL-vee, ubrogepant) and Reyvow (RAY-vow, lasmiditan) will be new oral meds to treat acute migraine in adults.

Ubrelvy is the first med in a new class called "gepants"...and Reyvow is the first med in a new class called "ditans."

But don't expect these meds to be on your formulary.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals